National Research Institute of Chinese Medicine, Ministry of Health and Welfare

Taïwan, Province de Chine

Retour au propriétaire

1-7 de 7 pour National Research Institute of Chinese Medicine, Ministry of Health and Welfare Trier par
Recheche Texte
Affiner par
Type PI
        Brevet 5
        Marque 2
Date
2023 3
2021 2
2020 2
Classe IPC
A61K 36/539 - Scutellaria (calotte) 3
A61K 36/575 - Magnolia 3
A61K 36/076 - Poria 2
A61K 36/282 - Artemisia, p.ex. armoise 2
A61K 36/428 - Trichosanthes 2
Voir plus
Statut
En Instance 3
Enregistré / En vigueur 4
Résultats pour

1.

Composition and method for treating cancer

      
Numéro d'application 17993343
Numéro de brevet 12076355
Statut Délivré - en vigueur
Date de dépôt 2022-11-23
Date de la première publication 2023-06-01
Date d'octroi 2024-09-03
Propriétaire
  • National Yang Ming Chiao Tung University (Taïwan, Province de Chine)
  • National Research Institute of Chinese Medicine, Ministry of Health and Welfare (Taïwan, Province de Chine)
Inventeur(s)
  • Lin, Tung-Yi
  • Lu, Mei-Kuang

Abrégé

Antrodia cinnamomea cultured in the presence of zinc sulfate and a carrier thereof, wherein the polysaccharide includes glucose and fucose. Also provided are a method for preparing the composition and a composition including the polysaccharide fraction obtained therefrom.

Classes IPC  ?

  • A61K 36/07 - Basidiomycota, p.ex. Cryptococcus
  • A61K 31/737 - Polysaccharides sulfatés, p.ex. sulfate de chondroïtine, sulfate de dermatane
  • A61P 35/00 - Agents anticancéreux

2.

PLANT COMPOSITION, TRADITIONAL CHINESE MEDICINE COMPOSITION AND USE THEREOF

      
Numéro d'application 18047697
Statut En instance
Date de dépôt 2022-10-19
Date de la première publication 2023-04-20
Propriétaire NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE, MINISTRY OF HEALTH AND WELFARE (Taïwan, Province de Chine)
Inventeur(s)
  • Su, Yi-Chang
  • Chiou, Wen-Hui
  • Shen, Yuh-Chiang
  • Wei, Wen-Chi
  • Tsai, Keng-Chang
  • Liao, Chia-Ching
  • Tseng, Yu-Hwei
  • Chiou, Chun-Tang
  • Lin, Yu-Chi
  • Wang, Li-Hsiang

Abrégé

The present invention relates to a plant composition, a traditional Chinese medicine composition and use thereof. The plant composition comprises Prepared Monkshood Daughter Root (Aconitum carmichaelii), Fragrant Solomonseal Rhizome (Polygonatum odoratum), Indian Bread (Poria cocos), Pinellia tuber (Pinellia ternata), Oriental Wormwood Herb (Artemisia scoparia), Scutellaria Root (Scutellaria baicalensis), Mongolian Snakegourd Fruit (Trichosanthes kirilowii), Magnolia Bark (Magnolia officinalis), Heartleaf Houttuynia Herb (Houttuynia cordata) and Baked Licorice Root and Rhizome (Glycyrrhiza glabra), which is used as a traditional Chinese medicine composition. In addition, the traditional Chinese medicine composition can be used to treat pulmonary embolism or pulmonary fibrosis.

Classes IPC  ?

3.

USE OF PLANT COMPOSITION, TRADITIONAL CHINESE MEDICINE COMPOSITION IN PREPARING MEDICINE FOR TREATING COVID-19

      
Numéro d'application 18047712
Statut En instance
Date de dépôt 2022-10-19
Date de la première publication 2023-04-20
Propriétaire NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE, MINISTRY OF HEALTH AND WELFARE (Taïwan, Province de Chine)
Inventeur(s)
  • Su, Yi-Chang
  • Chiou, Wen-Hui
  • Shen, Yuh-Chiang
  • Wei, Wen-Chi
  • Tsai, Keng-Chang
  • Liao, Chia-Ching
  • Tseng, Yu-Hwei
  • Chiou, Chun-Tang
  • Lin, Yu-Chi
  • Wang, Li-Hsiang
  • Huang, Chien-Hsien
  • Lin, Chia-Mo
  • Lin, Chi-Kuei
  • Huang, Yi-Chia
  • Lin, Chien-Jung
  • Lin, Jui-Shan
  • Yang, Ya-Sung
  • Chiu, Chun-Hsiang
  • Cheng, Shun-Ping
  • Kuo, Hsien-Hwa
  • Lin, Wu-Pu
  • Lin, Chen-Shien
  • Lai, Bo-Cheng
  • Hsu, Yuan-Nian
  • Tsai, Tsung-Lung
  • Hsu, Wei-Chen
  • Fong, Tieng-Siong
  • Huang, Yi-Wen
  • Tsai, Chia-I
  • Yang, Ya-Chen
  • Tsai, Ming-Che
  • Cheng, Ming-Huei
  • Huang, Shih-Wei

Abrégé

The present invention relates to a method of treating moderate or severe symptoms of COVID-19 using a plant composition. The plant composition comprises Prepared Monkshood Daughter Root (Aconitum carmichaelii), Fragrant Solomonseal Rhizome (Polygonatum odoratum), Indian Bread (Poria cocos), Pinellia tuber (Pinellia ternata), Oriental Wormwood Herb (Artemisia scoparia), Scutellaria Root (Scutellaria baicalensis), Mongolian Snakegourd Fruit (Trichosanthes kirilowii), Magnolia Bark (Magnolia officinalis), Heartleaf Houttuynia Herb (Houttuynia cordata), and Baked Licorice Root and Rhizome (Glycyrrhiza glabra), which is used as a traditional Chinese medicine composition.

Classes IPC  ?

4.

NRICM102

      
Numéro de série 97142645
Statut En instance
Date de dépôt 2021-11-24
Propriétaire NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE, MINISTRY OF HEALTH AND WELFARE (Taïwan, Province de Chine)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Chinese traditional medicinal herbs; Vitamin supplements; Calcium supplements; Food supplements; Mineral supplements; Herbal supplements; Prebiotic supplements; Dietary supplements; Nutritional supplements; Protein supplements; Enzyme food supplements; Powdered milk for babies; Food for babies; First-aid boxes, filled; Medicated shampoos

5.

Composition of plant ingredients, herbal composition and preparation method of the herbal composition

      
Numéro d'application 17128234
Numéro de brevet 11331362
Statut Délivré - en vigueur
Date de dépôt 2020-12-21
Date de la première publication 2021-11-18
Date d'octroi 2022-05-17
Propriétaire NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE, MINISTRY OF HEALTH AND WELFARE (Taïwan, Province de Chine)
Inventeur(s)
  • Su, Yi-Chang
  • Chiou, Wen-Hui
  • Kuo, Yao-Haur
  • Tsai, Keng-Chang
  • Liao, Chia-Ching
  • Wei, Wen-Chi
  • Chiou, Chun-Tang
  • Yeh, Kuo-Ming
  • Huang, Yi-Chia
  • Lin, Chien-Jung
  • Lin, Jui-Shan

Abrégé

A composition of plant ingredients, a herbal composition for inhibiting coronavirus and cytokine storm, and a preparation method of the herbal composition are introduced. The composition of plant ingredients has Heartleaf Houttuynia, Indigowoad Root, Fineleaf Nepeta, Saposhnikovia Root, Mulberry Leaf, Scutellaria Root, Mongolian Snakegourd Fruit, Magnolia Bark, Peppermint Herb and Baked Liquorice Root. The herbal composition has 1 to 20 parts by weight of Heartleaf Houttuynia, Indigowoad Root, Fineleaf Nepeta, Saposhnikovia Root, Mulberry Leaf, Scutellaria Root, Mongolian Snakegourd Fruit, Magnolia Bark, Peppermint Herb and Baked Liquorice Root. The preparation method contains providing Heartleaf Houttuynia, Indigowoad Root, Fineleaf Nepeta, Saposhnikovia Root, Mulberry Leaf, Scutellaria Root, Mongolian Snakegourd Fruit, Magnolia Bark, Peppermint Herb and Baked Liquorice Root; and soaking all the herbs described above in water and boiling the water to prepare a herbal liquid, the volume of which is about one-third of an initial volume of the water.

Classes IPC  ?

6.

NRICM101

      
Numéro de série 90084772
Statut Enregistrée
Date de dépôt 2020-07-31
Date d'enregistrement 2021-08-17
Propriétaire NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE, MINISTRY OF HEALTH AND WELFARE (Taïwan, Province de Chine)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Chinese traditional medicinal herbs; vitamin supplements; calcium supplements; food supplements; mineral supplements; herbal supplements; prebiotic supplements; dietary supplements; nutritional supplements; protein supplements; enzyme food supplements

7.

Anti-EGF like domain multiple 6 (EGFL6) antibodies

      
Numéro d'application 16652929
Numéro de brevet 11578121
Statut Délivré - en vigueur
Date de dépôt 2018-09-28
Date de la première publication 2020-07-30
Date d'octroi 2023-02-14
Propriétaire
  • Taipei Medical University (Taïwan, Province de Chine)
  • Changhua Christian Medical Foundation Changhua Christian Hospital (Taïwan, Province de Chine)
  • National Research institute of Chinese Medicine, Ministry of Health and Welfare (Taïwan, Province de Chine)
Inventeur(s)
  • Lee, Yu-Ching
  • Pan, Shiow-Lin
  • Huangfu, Wei-Chun
  • Huang, Tsui-Chin
  • Wei, Po-Li
  • Huang, Han-Li
  • Cheng, Chun-Chun
  • Huang, Cheng-Chiao
  • Tsai, Keng-Chang
  • Yeh, Kun-Tu
  • Sung, Ting-Yi
  • Chang, Fu-Ling

Abrégé

The invention relates to anti-EGF like domain multiple 6 antibody (anti-EGFL6 antibody) and cancer detection (or diagnosis) and treatment using the anti-EGFL6 antibody. The present invention creates anti-EGFL6 antibodies, particularly, a single-chain antibody fragments (scFv) and humanized antibody, which have ability in binding to EGFL6 and in inhibiting angiogenesis and cancer cell growth.

Classes IPC  ?

  • A61K 39/395 - Anticorps; Immunoglobulines; Immunsérum, p.ex. sérum antilymphocitaire
  • C07K 16/22 - Immunoglobulines, p.ex. anticorps monoclonaux ou polyclonaux contre du matériel provenant d'animaux ou d'humains contre des facteurs de croissance
  • C07K 16/00 - Immunoglobulines, p.ex. anticorps monoclonaux ou polyclonaux
  • A61K 39/00 - Préparations médicinales contenant des antigènes ou des anticorps